Soleil Securities Initiates Coverage on ONYX Pharmaceuticals (ONXX) with a Buy; Looking for Upside After ASH Conference
Tweet Send to a Friend
Soleil Securities initiates coverage on ONYX Pharmaceuticals (Nasdaq: ONXX) with a Buy rating. Price target $35.
Soleil analyst says, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Soleil analyst says, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
